Bristol Myers Squibb Stock Rises Nearly 3%, Outperforms Competitors
- Bristol Myers Squibb shares rose 2.67% to $51.86 on Wednesday
- The stock outperformed competitors like Johnson & Johnson, Pfizer, and Abbott Labs
- BMY closed $26.04 short of its 52-week high of $77.90
- Trading volume of 14.4M exceeded its 50-day average volume of 13.6M
- The story was auto-generated by Automated Insights using Dow Jones and FactSet data